Polysaccharide antigens of the capsule of Cryptococcus neoformans.
about
Dual specificity of Langerin to sulfated and mannosylated glycans via a single C-type carbohydrate recognition domainSurface glycans of Candida albicans and other pathogenic fungi: physiological roles, clinical uses, and experimental challenges.Cryptococcus-Related Immune Reconstitution Inflammatory Syndrome (IRIS): Pathogenesis and its Clinical ImplicationsVirulence factors of medically important fungiExperimental modulation of capsule size in Cryptococcus neoformansVirulence-Associated Enzymes of Cryptococcus neoformansCapsules from pathogenic and non-pathogenic Cryptococcus spp. manifest significant differences in structure and ability to protect against phagocytic cellsA role for LHC1 in higher order structure and complement binding of the Cryptococcus neoformans capsuleCryptococcosis in the era of AIDS--100 years after the discovery of Cryptococcus neoformans.Self-aggregation of Cryptococcus neoformans capsular glucuronoxylomannan is dependent on divalent cationsDirect inhibition of T-cell responses by the Cryptococcus capsular polysaccharide glucuronoxylomannan.Galactoxylomannans from Cryptococcus neoformans varieties neoformans and grubii are structurally and antigenically variable.Biosynthesis of a new UDP-sugar, UDP-2-acetamido-2-deoxyxylose, in the human pathogen Bacillus cereus subspecies cytotoxis NVH 391-98.Genetic relationship between Cryptococcus neoformans var. neoformans strains of serotypes A and DSpleen deposition of Cryptococcus neoformans capsular glucuronoxylomannan in rodents occurs in red pulp macrophages and not marginal zone macrophages expressing the C-type lectin SIGN-R1Characterization of a murine monoclonal antibody to Cryptococcus neoformans polysaccharide that is a candidate for human therapeutic studies.Identification of a bifunctional UDP-4-keto-pentose/UDP-xylose synthase in the plant pathogenic bacterium Ralstonia solanacearum strain GMI1000, a distinct member of the 4,6-dehydratase and decarboxylase family.Isotype switching increases efficacy of antibody protection against Cryptococcus neoformans infection in miceCharacterization of anticapsular monoclonal antibodies that regulate activation of the complement system by the Cryptococcus neoformans capsuleAssimilation of xylose, mannose, and mannitol for synthesis of glucuronoxylomannan of Cryptococcus neoformans determined by 13C nuclear magnetic resonance spectroscopy.Organ-dependent variation of capsule thickness in Cryptococcus neoformans during experimental murine infectionCryptococcus neoformans Galactoxylomannan contains an epitope(s) that is cross-reactive with Aspergillus GalactomannanHow sweet it is! Cell wall biogenesis and polysaccharide capsule formation in Cryptococcus neoformans.Functional cloning and characterization of a UDP- glucuronic acid decarboxylase: the pathogenic fungus Cryptococcus neoformans elucidates UDP-xylose synthesis.Cryptococcus neoformans var. grubii: separate varietal status for Cryptococcus neoformans serotype A isolates.Amphotericin B and fluconazole affect cellular charge, macrophage phagocytosis, and cellular morphology of Cryptococcus neoformans at subinhibitory concentrationsThe different binding patterns of two immunoglobulin M monoclonal antibodies to Cryptococcus neoformans serotype A and D strains correlate with serotype classification and differences in functional assays.Cryptococcus neoformans chemotyping by quantitative analysis of 1H nuclear magnetic resonance spectra of glucuronoxylomannans with a computer-simulated artificial neural networkMechanisms for induction of L-selectin loss from T lymphocytes by a cryptococcal polysaccharide, glucuronoxylomannan.In vitro and in vivo stability of a Cryptococcus neoformans [corrected] glucuronoxylomannan epitope that elicits protective antibodies.Molecular and idiotypic analyses of the antibody response to Cryptococcus neoformans glucuronoxylomannan-protein conjugate vaccine in autoimmune and nonautoimmune miceEarly induction of interleukin-12 by human monocytes exposed to Cryptococcus neoformans mannoproteins.Antibody interactions with the capsule of Cryptococcus neoformansSusceptibilities of Cryptococcus neoformans strains to platelet binding in vivo and to the fungicidal activity of thrombin-induced platelet microbicidal proteins in vitro.Role of mannoprotein in induction and regulation of immunity to Cryptococcus neoformans.Interdependency of interleukin-10 and interleukin-12 in regulation of T-cell differentiation and effector function of monocytes in response to stimulation with Cryptococcus neoformans.Effect of amphotericin B on capsule and cell size in Cryptococcus neoformans during murine infectionThe common Cryptococcus neoformans glucuronoxylomannan M2 motif elicits non-protective antibodies.Fc-dependent and Fc-independent opsonization of Cryptococcus neoformans by anticapsular monoclonal antibodies: importance of epitope specificityEffects of voriconazole on Cryptococcus neoformans.
P2860
Q24293019-242799C0-6970-40F0-82DA-6303AAAFDC89Q24625384-1DF36AA1-B480-428E-9492-30EB9F72CA41Q24629367-9CA0D8FF-2360-4F42-9A11-8A6C2BB59CFBQ24683790-CB01B47C-7CA4-4AD1-97F8-1B84D12CF309Q24805267-CA428446-7546-482C-8903-4FC2CBD43916Q26785005-BAA54474-B211-495E-ACB6-5E114787C451Q28478860-FAFFE6DD-18BC-4F3E-9C9A-DF94B46DAB72Q28538344-F1A4529D-C536-413D-A253-06DC25EE1EE0Q30424017-8B9D2999-5920-4B06-B658-57790DAE82F8Q30479935-06A32DB0-BDF3-4256-BE38-91F295664259Q33263249-2716B9AE-427F-4B3D-A415-35137E3F2E47Q33522882-6B358DAA-87D2-4227-A3CB-DFAC4122F9AEQ33597259-1D2FB3D1-EEC2-4DA8-BE4C-E497F6CF4E5EQ33674974-BC4ED080-9016-4AD9-ADF0-88051794B8C9Q33687443-5658A2AF-73DA-4744-B987-AAE92F88AC1FQ33693515-36BE21FB-AAEA-4064-981D-1AF182C4FA00Q33726568-29984C21-6EFA-403F-8797-B302ADEB430CQ33751509-242D6DB9-3CBA-4A8F-868F-AC91A454D04EQ33752366-77AB0E60-4E00-45C7-92CA-235A4E608434Q33755667-89E1A686-2314-484C-B023-09EB58B509EDQ33766953-52487AAE-F0D0-4C28-8F69-693E53F734F2Q33856355-D2019E68-9D8F-4AF5-B81F-214F8E09240AQ33894565-84350900-D456-455F-9F58-76C307FE53CFQ33946946-969227C6-2228-43FA-80D8-6B8D9F789BF0Q33959465-942D37B0-9085-4737-85BF-DADB60513B8BQ33975989-4447DEAF-5D95-4D90-BE18-A771D7702D12Q33991158-D754BC2D-FE18-4F7D-91F1-E082B7685B04Q33991281-C15C2243-6663-4EBD-A85D-458763488B0CQ33999974-E629F06A-6679-4736-85F6-B167B88E829FQ34001243-03CCCABA-8372-4F6B-8B19-8220B0C27E30Q34001701-96058AAF-BAC4-4B06-A2B1-9EB4203A4E57Q34003199-634752C7-86C1-40FA-9FCF-D8FFEF37DE07Q34004832-F3EA61D9-9D83-44AD-96ED-DBF84E72621AQ34006152-4F16058E-D586-4CD9-9738-2A47BD8F983DQ34007117-61195728-8297-4B96-9275-9EB776DE75B1Q34009212-0FC85024-919F-4230-B3E3-153F4395D2F2Q34077152-E11DB81B-BF8C-4E54-9A31-6733AA1C9A37Q34099803-438DF2B0-5504-440A-8F48-1C7B9FEE5FADQ34123230-0B1CBF02-8082-4ACF-98F8-F0D4D6595D91Q34142180-71AD4AE9-458B-4CDE-A3B8-7E7C39F5CBEF
P2860
Polysaccharide antigens of the capsule of Cryptococcus neoformans.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Polysaccharide antigens of the capsule of Cryptococcus neoformans.
@en
Polysaccharide antigens of the capsule of Cryptococcus neoformans.
@nl
type
label
Polysaccharide antigens of the capsule of Cryptococcus neoformans.
@en
Polysaccharide antigens of the capsule of Cryptococcus neoformans.
@nl
prefLabel
Polysaccharide antigens of the capsule of Cryptococcus neoformans.
@en
Polysaccharide antigens of the capsule of Cryptococcus neoformans.
@nl
P2860
P1476
Polysaccharide antigens of the capsule of Cryptococcus neoformans.
@en
P2093
J B Sundstrom
R Cherniak
P2860
P304
P407
P577
1994-05-01T00:00:00Z